| Quarterly Financials | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 832 | 888 | 901 | 998 | 994 | 1,043 | 1,111 | 1,312 | 1,367 | 1,346 | 1,410 |
| Expenses | 810 | 867 | 873 | 968 | 964 | 1,005 | 1,067 | 1,258 | 1,309 | 1,290 | 1,354 |
| EBITDA | 21 | 21 | 27 | 31 | 30 | 38 | 44 | 54 | 58 | 56 | 56 |
| Operating Profit % | 2 % | 2 % | 3 % | 3 % | 3 % | 3 % | 3 % | 3 % | 4 % | 4 % | 4 % |
| Depreciation | 5 | 7 | 6 | 6 | 6 | 7 | 7 | 8 | 8 | 9 | 9 |
| Interest | 13 | 13 | 14 | 18 | 16 | 17 | 10 | 12 | 10 | 11 | 11 |
| Profit Before Tax | 3 | 1 | 7 | 7 | 8 | 14 | 27 | 35 | 39 | 37 | 36 |
| Tax | -1 | 5 | 0 | 2 | 1 | -8 | 7 | 9 | 10 | 6 | 6 |
| Net Profit | 4 | -4 | 6 | 5 | 7 | 21 | 21 | 26 | 30 | 31 | 30 |
| EPS in ₹ | 8.67 | 1.49 | 15.18 | 3.24 | 4.21 | 5.73 | 4.62 | 5.43 | 5.85 | 5.91 | 6.39 |
Entero Healthcare Solutions
Entero Healthcare Solutions
1,106.80
+9.60
(0.87%)
Key Fundamentals
Market Cap
4,773.80 Cr
EPS
21.80
PE Ratio
41.11
Dividend Yield
0.00 %
Industry
Retail 52 Week High
1,584.25
52 Week Low
1,044.90
PB Ratio
2.80
Debt to Equity
0.22
Sector
Pharmacy Retail Analyst Rating and Forecast
- By Refinitiv from3 analysts
Actual
Company News
View All News
Entero Healthcare Solutions' board has approved the complete sale of its subsidiary Suprabhat Pharmaceutical. Additionally, the company plans to acquire a 60% stake in Ace Cardiopathy Solutions. These strategic moves represent significant portfolio restructuring for the healthcare company.
Entero Healthcare Solutions Reports 28% Revenue Growth to Rs 1,404 Crores in Q1 FY26Aug 19, 2025
Entero Healthcare Solutions Limited reported revenue of Rs 1,404 crores for the quarter ended June 30, 2025, representing a 28% year-over-year increase. The healthcare distribution company achieved gross profit of Rs 140 crores, up 40% year-over-year, with gross margin expanding to 9.9%. EBITDA grew 66% to Rs 50 crores with margin improving to 3.6%, while profit after tax increased 47% to Rs 30 crores. The company serves over 71,000 retail pharmacies and 2,500+ hospitals across 469 districts through 102 warehouses, offering 74,700+ SKUs from 2,600+ manufacturers. Net working capital improved from 71 days to 66 days. Management targets 30% revenue growth for FY26, EBITDA margin above 4%, and working capital reduction to 60 days. The company added 11,000 customers during the quarter and announced Rs 400+ crores of acquisitions in the previous quarter, targeting Rs 500 crores of inorganic revenue addition in FY26.
GIC Private Limited, acting on behalf of the Government of Singapore, sold 9,846 equity shares in Entero Healthcare Solutions Limited through open market transactions. The sale reduced GIC's shareholding from 3.164% to 3.141% of the total share capital. The transaction was completed on August 11, 2025. Entero Healthcare Solutions is listed on both the National Stock Exchange of India Limited and BSE Limited. The company's total equity share capital stands at 43,508,907 shares. GIC previously held 5.16% stake in the company and has been gradually reducing its position through multiple transactions since February 2024.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
763.50 | #1 9,105.90 | 51.34 | #1 6,184.70 | 9.18 | #1 150 | #1 195.80 | 39.87 | |
1,106.80 | #2 4,773.80 | #1 41.11 | #2 5,135.30 | #1 30.45 | #2 107 | #2 47.32 | 45.72 | |
44.15 | 60.20 | - | 9.20 | -4.17 | -2 | -166.67 | 62.31 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
30.45 %
Net Income Growth
169.85 %
Cash Flow Change
-109.97 %
ROE
150.83 %
ROCE
67.13 %
EBITDA Margin (Avg.)
28.04 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 749 | 836 | 1,126 | 1,309 | 2,345 | 2,703 |
| Fixed Assets | 186 | 189 | 262 | 268 | 289 | 559 |
| Current Assets | 552 | 636 | 851 | 1,023 | 2,011 | 2,076 |
| Capital Work in Progress | 2 | 2 | 1 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 58 |
| Other Assets | 561 | 645 | 863 | 1,041 | 2,056 | 2,085 |
| Total Liabilities | 749 | 836 | 1,126 | 1,309 | 2,345 | 2,703 |
| Current Liabilities | 269 | 291 | 462 | 624 | 602 | 845 |
| Non Current Liabilities | 56 | 58 | 101 | 87 | 102 | 87 |
| Total Equity | 424 | 487 | 563 | 598 | 1,641 | 1,770 |
| Reserve & Surplus | -16 | -32 | -62 | -73 | 1,593 | 1,676 |
| Share Capital | 439 | 517 | 4 | 4 | 44 | 44 |
Cash Flow
| Cash Flow | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -23 | -11 | 14 | -21 | 122 | 82 |
| Investing Activities | -203 | -31 | -162 | -49 | -704 | 232 |
| Operating Activities | -37 | -69 | -35 | -45 | -37 | -77 |
| Financing Activities | 217 | 89 | 211 | 73 | 863 | -74 |
Share Holding
| % Holding | Sept 2023 | Feb 2024 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 78.85 % | 52.44 % | 52.44 % | 52.44 % | 52.44 % | 52.44 % | 52.42 % | 52.42 % |
| FIIs | 0.00 % | 0.00 % | 23.30 % | 23.32 % | 23.82 % | 22.21 % | 19.92 % | 17.20 % |
| DIIs | 0.00 % | 1.36 % | 2.28 % | 2.06 % | 7.73 % | 8.77 % | 9.64 % | 10.18 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 5.72 % | 4.95 % | 5.00 % | 4.06 % | 4.36 % | 5.41 % | 6.99 % |
| Others | 21.15 % | 40.48 % | 17.03 % | 17.18 % | 11.95 % | 12.23 % | 12.61 % | 13.20 % |
| No of Share Holders | 51 | 58 | 80,864 | 66,400 | 36,767 | 33,172 | 33,159 | 33,338 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 28 Aug 2024 |  Annual General Meeting | NA | 28 Aug 2024 | 1,245.00 | 1,301.20 |
| 12 Nov 2024 |  Quarterly Result Announcement | NA | 12 Nov 2024 | 1,387.70 | 1,477.80 |
| 12 Feb 2025 | Quarterly Result Announcement | NA | 12 Feb 2025 | 1,372.25 | 1,328.65 |
| 27 May 2025 | Quarterly Result Announcement | NA | 27 May 2025 | 1,443.60 | 1,477.30 |
| 08 Aug 2025 | Quarterly Result Announcement | NA | 08 Aug 2025 | 1,265.95 | 1,257.25 |
| 18 Sept 2025 | Annual General Meeting | NA | 18 Sept 2025 | 1,158.70 | 1,132.30 |
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Oct 08, 2025
Oct 08, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Oct 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 03, 2025
Oct 03, 2025Announcement under Regulation 30 (LODR)-Diversification / DisinvestmentSep 29, 2025
Sep 29, 2025Announcement under Regulation 30 (LODR)-AcquisitionSep 29, 2025
Sep 29, 2025Board Meeting Outcome for Outcome Of Board MeetingSep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 25, 2025
Sep 25, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 19, 2025
Sep 19, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 18, 2025
Sep 18, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 18, 2025
Sep 18, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 18, 2025
Sep 18, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 18, 2025
Sep 18, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 10, 2025
Sep 10, 2025Announcement under Regulation 30 (LODR)-Change in Corporate Office AddressSep 03, 2025
Sep 03, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 26, 2025
Aug 26, 2025General UpdatesAug 25, 2025
Aug 25, 2025Business Responsibility and Sustainability Reporting (BRSR)Aug 25, 2025
Aug 25, 2025Submission Of Notice Of 7Th Annual General Meeting Scheduled To Be Held On September 18 2025 At 11:30 AM (IST)Aug 25, 2025
Aug 25, 2025Reg. 34 (1) Annual Report.Aug 25, 2025
Aug 25, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 21, 2025
Aug 21, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 19, 2025
Aug 19, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 11, 2025
Aug 11, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 10, 2025
Aug 10, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 08, 2025
Aug 08, 2025Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 08, 2025
Aug 08, 2025Unaudited Financial Results For The Quarter Ended June 30 2025Aug 08, 2025
Aug 08, 2025Board Meeting Outcome for Outcome Of Board MeetingAug 08, 2025
Aug 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 30, 2025
Jul 30, 2025Board Meeting Intimation for Approval And Take On Record The Standalone And Consolidated Unaudited Financial Results Of The Company For The Quarter Ended June 30 2025.Jul 25, 2025
Jul 25, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Jul 09, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 08, 2025
Jul 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 26, 2025
Jun 26, 2025Closure of Trading WindowJun 25, 2025
Jun 25, 2025Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Jun 18, 2025
Jun 18, 2025Intimation For Grant Of 5900 Options Pursuant To Entero Employee Stock Option Plan 2023 To The Eligible Employees Of The Company.
Jun 18, 2025
Jun 18, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On June 18 2025Jun 18, 2025
Jun 18, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 04, 2025
Jun 04, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
May 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 29, 2025
May 29, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 28, 2025
May 28, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 27, 2025
May 27, 2025Change In Designation Of Mr. Kevin Daftary From Non Executive Non Independent Director To Nominee DirectorMay 27, 2025
May 27, 2025Appointment Of M/S. BNP & Associates Practicing Company Secretaries (Firm Registration No. P2014MH037400) As The Secretarial Auditor Of The CompanyMay 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-AcquisitionMay 27, 2025
May 27, 2025Announcement Under Regulation 30 (LODR) - Change In Authorization Of Key Managerial Personnel ("KMP") For Determining Materiality Of An Event Or InformationMay 27, 2025
May 27, 2025Results - Audited Financial Results For Quarter And Year Ended March 31 2025.May 27, 2025
May 27, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On May 27 2025May 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 23, 2025
May 23, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Invesco India Smallcap Fund Direct - Growth | 0.07% | -261428 | -0.41% | -0.69% | |
| Invesco India Multicap Fund Direct-Growth | 0.00% | -160075 | -0.47% | -0.63% | |
 Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth | 0.24% | -765 | -0.02% | -0.04% | |
 Groww Nifty Total Market Index Fund Direct - Growth | 0.01% | -2 | 0.00% | 0.00% | |
 Angel One Nifty Total Market Index Fund Direct - Growth | 0.01% | 1 | 0.00% | 0.00% | |
 Bandhan Nifty Total Market Index Fund Direct-Growth | 0.01% | -1 | 0.00% | 0.00% | |
 HSBC Consumption Fund Direct - Growth | 0.67% | 0 | -0.06% | -0.13% | |
| Invesco India Aggressive Hybrid Fund Direct - Growth | 0.42% | 0 | -0.04% | -0.09% | |
| Invesco India Contra Fund Direct-Growth | 0.92% | 0 | -0.06% | -0.13% | |
| Invesco India ELSS Tax Saver Fund Direct-Growth | 0.90% | 0 | -0.05% | -0.13% | |
| Invesco India Equity Savings Fund Direct - Growth | 0.41% | 0 | -0.03% | -0.09% | |
 Mirae Asset Nifty Total Market Index Fund Direct-Growth | 0.01% | 0 | 0.00% | 0.00% |
Technical Indicators
RSI(14)
Neutral 45.72
ATR(14)
Less Volatile 36.74
STOCH(9,6)
Neutral 60.84
STOCH RSI(14)
Neutral 62.75
MACD(12,26)
Bullish 3.61
ADX(14)
Weak Trend 7.82
UO(9)
Bearish 49.07
ROC(12)
Downtrend And Accelerating -0.66
WillR(14)
Neutral -40.54
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
